Tech Company M&A Transactions
ForSight VISION5 Acquisition
On 8/11/2016, ForSight VISION5 was purchased by Allergan Plc. Allergan Plc disclosed that the acquisition price was $95 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/11/2016
Transaction Type
M&A
Amount
$95,000,000
M&A Terms
Allergan gets access to ForSight's lead development program, a periocular ring designed for extended drug delivery and reduced elevated intraocular pressure (IOP) in glaucoma patients. Allergan agreed to acquire ForSight for $95 million upfront and a milestone payment of an undisclosed amount, tied to the launch of ForSight's lead development program.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
191 Jefferson Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Privately held ForSight VISION5 was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, which focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Angela Macfarlane
Chief Technical Officer
Cary Reich
Founder
Eugene Juan
Browse more venture capital transactions:
Prev: 8/11/2016: Wefunder venture capital transaction
Next: 8/11/2016: FullContact venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs